Human adenovirus type 5 vectors expressing rabies glycoprotein

Vaccine

Volumn 14, Issue 13, 1996, Pages 1257-1264

  Yarosh, Oksana K ^a,b   Wandeler, Alex I ^b   Graham, Frank L ^a   Campbell, James B ^c   Prevec, Ludvik ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adenovirus vector; Expression vector; Rabies vaccine

Indexed keywords

GLYCOPROTEIN; RABIES VACCINE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES; VACCINATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, VIRAL; CELLS, CULTURED; DNA; FEMALE; GENETIC VECTORS; HUMANS; MEPHITIDAE; MICE; MICE, INBRED BALB C; RABIES VACCINES; VACCINES, SYNTHETIC;

EID: 0030250559     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00012-6     Document Type: Article

References (47)

1. 1 Steck, F., Wandeler, A., Bichsel, P., Capt, S., Hafliger, U. and Schneider, L. Oral immunisation of foxes against rabies: laboratory and field studies. Comp. Immunol. Microbiol. Infect. Dis. 1982, 5, 165-171
2. 2 Wandeler, A.I., Capt, S., Kappeler, A. and Hauser, R. Oral immunization of wildlife against rabies: concept and first field experiments. Rev. Infect. Dis. 1988, 10, S649-S653
3. 3 Shope, R.E. and Tesh, R.B. The ecology of rhabdoviruses that infect vertebrates. In: The Rhabdoviruses (Ed. Wagner, R.R.). Plenum Press, New York, 1987, pp. 509-534
4. 4 Campbell, J.B. and Zhang, Y. Rabies virus infection: new vaccines and strategies in immunization. In: Control of Virus Diseases (Ed. Kurstak, E.), 2nd Edn. Marcel Dekker, New York, 1993, pp. 267-306
5. 5 Krebs, J.W., Strine, T.W. and Childs, J.E. Rabies surveillance in the United States during 1992. J. Am. Vet. Med. Assoc. 1993, 203, 1718-1731
6. 6 Raccoon rabies epizootic-United States, 1994. Morb. Mortal. Wkly. Rep. 1994, 43, 269-273
7. 7 Meehan, S.K. Editorial. Rabies epizootic in coyotes combated with oral vaccination program. J. Am. Vet. Med. Assoc. 1995, 206, 1097-1099
8. 8 Johnston, D.H., Voigt, D.R., MacInnes, C.D., Bachmann, P., Lawson, K.F. and Rupprecht, C.E. An aerial baiting system for the distribution of attenuated or recombinant rabies vaccines for foxes, raccoons, and skunks. Rev. Infect. Dis. 1988, 10, S660-664
9. 9 Rupprecht, C.E., Wiktor, T.J., Johnston, D.H. et al. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc. Natl Acad. Sci. USA 1986, 83, 7947-7950
10. 10 Rupprecht, C.E., Charlton, K.M., Artois, M. et al. Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis). J. Wildlife Dis. 1990, 26, 99-102
11. 11 Artois, M., Guittre, C., Thomas, I., Leblois, H., Brochier, B. and Barrat, J. Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: a comparison. Vaccine 1992, 10, 524-528
12. 12 Wiktor, T.J., Plotkin, S.A. and Grella, D.W. Human cell culture rabies vaccine. Antibody response in man. J. Am. Med. Assoc. 1973, 224, 1170-1171
13. 13 Cox, J.H., Dietzschold, B. and Schneider, L.G. Rabies virus glycoprotein. II. Biological and serological characterization. Infect. Immun. 1977, 16, 754-759
14. 14 Lafon, M., Wiktor, T.J. and Macfarlan, R.I. Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J. Gen. Virol. 1983, 64, 843-851
15. 15 Bunschoten, H., Klapmuts, R.J., Claassen, I.J.T.M., Reyneveld, S.D., Osterhaus, A.D.M.E. and Uytdehaag, F.G.C.M. Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein. J. Gen. Virol. 1989, 70, 1513-1521
16. 16 Celis, E., Miller, R.W., Wiktor, T.J., Dietzschold, B. and Koprowski, H. Isolation and characterization of human T cell lines and clones reactive to rabies virus: antigen specificity and production of interferon-gamma. J. Immunol. 1986, 136, 692-697
17. 17 Celis, E., Ou, D., Dietzschold, B. and Koprowski, H. Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients. J. Virol. 1988, 62, 3128-3134
18. 18 Kawano, H., Mifune, K., Ohuchi, M. et al. Protection against rabies in mice by a cytotoxic T cell clone recognizing the glycoprotein of rabies virus. J. Gen. Virol. 1990, 71, 281-287
19. 19 Kieny, M.P., Lathe, R. and Drillien, R. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 1984, 312, 163-166
20. 20 Rupprecht, C.E., Hamir, A.N., Johnston, D.H. and Koprowski, H. Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Rev. Infect. Dis. 1988, 10, S803-S809
21. 21 Brochier, B., Boulanger, D., Costy, F. and Pastoret, P.P. Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus. Vaccine 1994, 12, 1368-1371
22. 22 Hruby, D.E. Vaccinia virus vectors: new strategies for producing recombinant vaccines. Clin. Microbiol. Rev. 1990, 3, 153-170
23. 23 Kaplan, C. Vaccinia virus: a suitable vehicle for recombinant vaccines?. Archs Virol. 1989, 106, 127-139
24. 24 Berkner, K.L. Development of adenovirus vectors for the expression of heterologous genes. Biotechology 1988, 6, 616-628
25. 25 Graham, F.L. and Prevec, L. Manipulation of adenovirus vectors. In: Methods in Molecular Biology. Gene Transfer and Expression Protocols (Ed. Murray, E.J.), Vol. 7. The Humana Press, Clifton, New Jersey, 1991, pp. 109-129
26. 26 Prevec, L., Campbell, J.B., Christie, B.S., Belbeck, L. and Graham, F.L. A recombinant human adenovirus vaccine against rabies. J. Infect. Dis. 1990, 161, 27-30
27. 27 Charlton, K.M., Artois, M., Prevec, L. et al. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Archs Virol. 1992, 123, 169-179
28. 28 Graham, F.L., Smiley, J., Russell, W.C. and Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977, 36, 59-72
29. 29 Hitt, M., Bett, A.J., Prevec, L. and Graham, F.L. Construction and propagation of human adenovirus vectors. In: Cell Biology: A Laboratory Handbook (Ed. Celis, J.). Vol. 1. Academic Press, San Diego, CA, 1994, pp. 479-490
30. 30 Graham, F.L. and Prevec, L. Adenovirus expression vectors and recombinant vaccines. In: Vaccines: New Approaches to Immunological Problems (Ed. Ellis, R.W.). Butterworth-Heinemann, NY, 1992, pp. 363-390
31. 31 Bett, A.J., Prevec, L. and Graham, F.L. Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 1993, 67, 5911-5921
32. 32 Hitt, M., Bett, A.J., Addison, C.L., Prevec, L. and Graham, F.L. Techniques for human adenovirus vector construction and characterization. In: Methods in Molecular Genetics (Ed. Adolph, K.W.). Vol. 7, Academic Press, San Diego, CA, 1995, pp. 13-30
33. 33 Berkner, K.L. and Sharp, P.A. Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant. Nucl. Acids Res. 1985, 13, 841-857
34. 34 Graham, F.L. and van der Eb, A. A new technique for the assay of infectivity of human adenovirus type 5 DNA. Virology 1973, 52, 456-467
35. 35 Rowe, D.T., Branton, P.E. and Graham, F.L. The kinetics of synthesis of early viral proteins in KB cells infected with wild-type and transformation-defective host-range mutants of human adenovirus type 5. J. Gen. Virol. 1984, 65, 585-597
36. 36 Barton, L.D. and Campbell, J.B. Measurement of rabies-specific antibodies in carnivores by an enzyme-linked immunosorbent assay. J. Wildlife Dis. 1988, 24, 246-258
37. 37 Zalan, E., Wilson, C. and Pukitis, D. A microtest for the quantitation of rabies virus neutralizing antibodies. J. Biol. Stand. 1979, 7, 213-220
38. 38 Kozak, M. The scanning model for translation: an update. J. Cell Biol. 1989, 108, 229-241
39. 39 Shaw, A.R., Ziff, E.B. Transcripts from the adenovirus-2 major late promoter yield a single early family of 3′ coterminal mRNAs and five late families. Cell 1980, 22, 905-916
40. 40 Akusjarvi, G. and Persson, H. Controls of RNA splicing and termination in the major late adenovirus transcription unit. Nature 1981, 292, 420-426
41. 41 Nevins, J.R. and Wilson, M.C. Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing. Nature 1981, 290, 113-118
42. 42 G. Martins, The replication of hAd5 in MDBK, MDCK, HeLa and L cells. M.Sc. thesis, McMaster University, Hamilton, ON, 1991
43. 43 Johnson, D.C., Ghosh-Choudhury, G., Smiley, J.R., Fallis, L. and Graham, F.L. Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 1988, 164, 1-14
44. 44 Schneider, M., Graham, F.L. and Prevec, L. Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors. J. Gen. Virol. 1989, 70, 417-427
45. 45 Mittal, S.K., McDermott, M.R., Johnson, D.C., Prevec, L. and Graham, F.L. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 1993, 28, 67-90
46. 46 Anderson, K.P. and Klessig, D.F. Altered mRNA splicing in monkey cells abortively infected with human adenovirus may be responsible for inefficient synthesis of the virion fiber polypeptide. Proc. Natl Acad. Sci. USA 1984, 81, 4023-4027
47. 47 Wandeler, A.I. Oral immunization of wildlife. In: Natural History of Rabies (Ed. Baer, G.M.). CRC Press, Boca Raton, FL, 1991, pp. 485-503